BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blok B, Van Kerrebroeck P, de Wachter S, Ruffion A, Van der Aa F, Jairam R, Perrouin‐verbe MA, Elneil S. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12‐month results from the RELAX‐OAB study. Neurourology and Urodynamics 2019;38:689-95. [DOI: 10.1002/nau.23892] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Moore CK, Rueb JJ, Derisavifard S. What Is New in Neuromodulation? Curr Urol Rep 2019;20:55. [PMID: 31388779 DOI: 10.1007/s11934-019-0920-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
2 Wang A, Rourke E, Sebesta E, Dmochowski R. Axonics® system for treatment of overactive bladder syndrome and urinary urgency incontinence. Expert Rev Med Devices 2021;18:727-32. [PMID: 34187274 DOI: 10.1080/17434440.2021.1947794] [Reference Citation Analysis]
3 Coolen RL, Groen J, Blok B. Electrical stimulation in the treatment of bladder dysfunction: technology update. Med Devices (Auckl) 2019;12:337-45. [PMID: 31572023 DOI: 10.2147/MDER.S179898] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Phillips A. Sacral neuromodulation system for treating refractory overactive bladder. Br J Nurs 2020;29:S30-7. [PMID: 33035097 DOI: 10.12968/bjon.2020.29.18.S30] [Reference Citation Analysis]
5 De Wachter S, Knowles CH, Elterman DS, Kennelly MJ, Lehur PA, Matzel KE, Engelberg S, Van Kerrebroeck PEV. New Technologies and Applications in Sacral Neuromodulation: An Update. Adv Ther 2020;37:637-43. [PMID: 31875299 DOI: 10.1007/s12325-019-01205-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
6 Stanton AP, Chen AH. New options for managing fecal incontinence in women. JAAPA 2020;33:50-2. [PMID: 32740116 DOI: 10.1097/01.JAA.0000684168.68881.61] [Reference Citation Analysis]
7 Oelke M, Addali M, Reisenauer C. What uro-gynecologists should know about sacral neuromodulation (SNM) for the treatment of refractory overactive bladder. Arch Gynecol Obstet 2019;299:1243-52. [PMID: 30941558 DOI: 10.1007/s00404-019-05127-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Kim Y, Ortega M, Von Bargen E. Updates in treating fecal incontinence in women. Curr Opin Obstet Gynecol 2020;32:461-7. [PMID: 32925257 DOI: 10.1097/GCO.0000000000000660] [Reference Citation Analysis]
9 Averbeck MA, Moreno-Palacios J, Aparicio A. Is there a role for sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction? Int Braz J Urol 2020;46:891-901. [PMID: 32758301 DOI: 10.1590/S1677-5538.IBJU.2020.99.10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
10 Mass-Lindenbaum M, Calderón-Pollak D, Goldman HB, Pizarro-Berdichevsky J. Sacral neuromodulation - when and for who. Int Braz J Urol 2021;47:647-56. [PMID: 33621015 DOI: 10.1590/S1677-5538.IBJU.2021.99.08] [Reference Citation Analysis]
11 Benson K, McCrery R, Taylor C, Padron O, Blok B, de Wachter S, Pezzella A, Gruenenfelder J, Pakzad M, Perrouin-Verbe MA, Van Kerrebroeck P, Mangel J, Peters K, Kennelly M, Shapiro A, Lee U, Comiter C, Mueller M, Goldman H, Lane F. One-year outcomes of the ARTISAN-SNM study with the Axonics System for the treatment of urinary urgency incontinence. Neurourol Urodyn 2020;39:1482-8. [PMID: 32339339 DOI: 10.1002/nau.24376] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
12 Jottard K, Van den Broeck S, Komen N, Bruyninx L, De Wachter S. Treatment of Fecal Incontinence With a Rechargeable Sacral Neuromodulation System: Efficacy, Clinical Outcome, and Ease of Use-Six-Month Follow-Up. Neuromodulation 2020. [PMID: 33107663 DOI: 10.1111/ner.13298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Tilborghs S, De Wachter S. Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects. Expert Review of Medical Devices. [DOI: 10.1080/17434440.2022.2032655] [Reference Citation Analysis]
14 Dudding TC, Lehur PA, Sørensen M, Engelberg S, Bertapelle MP, Chartier-Kastler E, Everaert K, Van Kerrebroeck P, Knowles CH, Lundby L, Matzel KE, Muñoz-Duyos A, Rydningen MB, de Wachter S. Reprogramming Sacral Neuromodulation for Sub-Optimal Outcomes: Evidence and Recommendations for Clinical Practice. Neuromodulation 2021. [PMID: 34264542 DOI: 10.1111/ner.13494] [Reference Citation Analysis]
15 Noblett K, Crowder C. Neuromodulation. Obstet Gynecol Clin North Am 2021;48:677-88. [PMID: 34416945 DOI: 10.1016/j.ogc.2021.05.018] [Reference Citation Analysis]
16 Blok B, Van Kerrebroeck P, de Wachter S, Ruffion A, Van der Aa F, Perrouin-Verbe MA, Elneil S. Two-year safety and efficacy outcomes for the treatment of overactive bladder using a long-lived rechargeable sacral neuromodulation system. Neurourol Urodyn 2020;39:1108-14. [PMID: 32243625 DOI: 10.1002/nau.24317] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Araklitis G, Baines G, da Silva AS, Robinson D, Cardozo L. Recent advances in managing overactive bladder. F1000Res 2020;9:F1000 Faculty Rev-1125. [PMID: 32968482 DOI: 10.12688/f1000research.26607.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Poole RL, Dale M, Morgan H, Oladapo T, Brookfield R, Morris R. Axonics Sacral Neuromodulation System for Treating Refractory Overactive Bladder: A NICE Medical Technologies Guidance. Appl Health Econ Health Policy 2021. [PMID: 34964090 DOI: 10.1007/s40258-021-00701-0] [Reference Citation Analysis]